fusidic acid has been researched along with trimethoprim in 33 studies
| Studies (fusidic acid) | Trials (fusidic acid) | Recent Studies (post-2010) (fusidic acid) | Studies (trimethoprim) | Trials (trimethoprim) | Recent Studies (post-2010) (trimethoprim) |
|---|---|---|---|---|---|
| 1,742 | 117 | 344 | 6,989 | 845 | 894 |
| Protein | Taxonomy | fusidic acid (IC50) | trimethoprim (IC50) |
|---|---|---|---|
| Chain A, Dihydrofolate reductase | Bacillus anthracis | 77200 | |
| Chain A, dihydrofolate reductase (DHFR) | Bacillus anthracis | 77200 | |
| Dihydrofolate reductase | Mycobacterium avium | 0.2588 | |
| Dihydrofolate reductase | Homo sapiens (human) | 1.8206 | |
| Dihydrofolate reductase | Lacticaseibacillus casei | 0.3493 | |
| Dihydrofolate reductase type 1 | Escherichia coli | 0.25 | |
| Dihydrofolate reductase | Neisseria gonorrhoeae | 0.45 | |
| Thymidylate synthase | Homo sapiens (human) | 3.405 | |
| Dihydrofolate reductase | Staphylococcus aureus | 0.0875 | |
| Thymidylate synthase | Escherichia coli K-12 | 3.405 | |
| Dihydrofolate reductase | Escherichia coli K-12 | 0.6064 | |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Plasmodium falciparum K1 | 0.01 | |
| Dihydrofolate reductase type 1 from Tn4003 | Staphylococcus aureus | 0.023 | |
| Dipeptidyl peptidase 4 | Rattus norvegicus (Norway rat) | 2.7 | |
| Dihydrofolate reductase | Pneumocystis carinii | 0.7061 | |
| Dihydrofolate reductase | Candida albicans | 0.1361 | |
| Dipeptidyl peptidase 4 | Homo sapiens (human) | 2.7 | |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.45 | |
| Metabotropic glutamate receptor 5 | Rattus norvegicus (Norway rat) | 2.73 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 2.8 | |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Toxoplasma gondii | 3.2206 | |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Plasmodium berghei ANKA | 0.12 | |
| Dihydrofolate reductase | Streptococcus pneumoniae TIGR4 | 0.0297 | |
| Dihydrofolate reductase | Lactococcus lactis subsp. lactis Il1403 | 0.45 | |
| Dihydrofolate reductase | Bacillus anthracis | 4.77 | |
| Dihydrofolate reductase | Rattus norvegicus (Norway rat) | 1.244 | |
| Dihydrofolate reductase | Pneumocystis jirovecii | 0.092 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (54.55) | 18.7374 |
| 1990's | 3 (9.09) | 18.2507 |
| 2000's | 5 (15.15) | 29.6817 |
| 2010's | 7 (21.21) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
| Arpin, C; Fournier, M; Gagné, S; Hernould, M; Quentin, C | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bavari, S; Bowlin, TL; Houseweart, C; Moir, DT; Opperman, TJ; Panchal, RG; Peet, NP; Williams, JD | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Floyd, JL; Floyd, JT; Kumar, SH; Smith, KP; Varela, MF | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
| Hamilton-Miller, JM | 1 |
| Benn, RA | 1 |
| Isaksson, LA; Takata, R | 1 |
| Darrell, JH; Uttley, AH | 1 |
| Hossack, G; Paddock, G; Parsons, RL | 1 |
| Gibson, JR; Harvey, SG; Jaafar, RB; Lumpur, K; Marks, P; Pettit, JH | 1 |
| Chandrasekar, PH; DeLorenzo, W; Levine, DP; Unowsky, J | 1 |
| Nielsen, H | 1 |
| Natunen, T; Saunders, L | 1 |
| Jeljaszewicz, J; Lund, E; Pulverer, G | 1 |
| Pulverer, G | 1 |
| Jeljaszewicz, J; Pulverer, G | 1 |
| Lacey, RW; Richmond, MH | 1 |
| Kjeldgaard, NO; Lund, E | 1 |
| Derambure, S; Deroubaix, P; Hogedez, G; Lelong, M; Polaert, J; Sorez, JP; Thelliez, P; Vanlaeys, R | 1 |
| Plommet, M; Taylor, AG | 1 |
| Vacek, V | 1 |
| Nakhla, LS | 1 |
| Emmerson, AM; Grüneberg, RN; Ridgway, GL | 1 |
| Hay, RJ; Nasher, MA | 1 |
| Bourdeau, P; Pellerin, JL; Person, JM; Sebbag, H | 1 |
| Berger-Bächi, B; Ender, M; McCallum, N | 1 |
| Brennan, OM; Coleman, DC; Deasy, EC; Ehricht, R; Kinnevey, PM; Monecke, S; Rossney, AS; Shore, AC | 1 |
3 review(s) available for fusidic acid and trimethoprim
| Article | Year |
|---|---|
Antimicrobial agents acting against anaerobes.
Topics: Aminoglycosides; Anaerobiosis; Animals; Anti-Bacterial Agents; Bacteria; Chloramphenicol; Clindamycin; Colistin; Disease Models, Animal; Erythromycin; Fusidic Acid; Humans; Lactams; Lincomycin; Microbial Sensitivity Tests; Nitrofurans; Nitroimidazoles; Polymyxins; Rifamycins; Sulfamethoxazole; Tetracyclines; Trimethoprim; Vancomycin | 1975 |
Antibiotics: use and abuse in office practice.
Topics: Anti-Bacterial Agents; Cephalosporins; Clindamycin; Erythromycin; Fusidic Acid; Humans; Kidney Diseases; Lincomycin; Mycoplasma Infections; Penicillins; Private Practice; Respiratory Tract Infections; Skin Diseases, Infectious; Staphylococcal Infections; Streptococcal Infections; Substance-Related Disorders; Sulfonamides; Tetracyclines; Trimethoprim | 1977 |
Antibiotics in the peri-operative period.
Topics: Acute Kidney Injury; Aminoglycosides; Anesthesia; Anti-Bacterial Agents; Bronchitis; Cephalosporins; Drug Combinations; Endocarditis, Bacterial; Fusidic Acid; Gentamicins; Humans; Infusions, Parenteral; Lincomycin; Penicillins; Pneumonia; Postoperative Complications; Rifamycins; Staphylococcal Infections; Sulfamethoxazole; Surgical Procedures, Operative; Tetracyclines; Trimethoprim; Urinary Tract Infections | 1976 |
1 trial(s) available for fusidic acid and trimethoprim
| Article | Year |
|---|---|
Trimethoprim-polymyxin B sulfate cream versus fusidic acid cream in the treatment of pyodermas: an update.
Topics: Double-Blind Method; Drug Combinations; Female; Fusidic Acid; Humans; Male; Polymyxin B; Pyoderma; Trimethoprim | 1991 |
29 other study(ies) available for fusidic acid and trimethoprim
| Article | Year |
|---|---|
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Role of the AheABC efflux pump in Aeromonas hydrophila intrinsic multidrug resistance.
Topics: Aeromonas hydrophila; Anti-Bacterial Agents; Bacterial Proteins; Biological Transport, Active; Dipeptides; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA; Substrate Specificity | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
Topics: Bacterial Proteins; Drug Resistance, Bacterial; Indoles; Microbial Sensitivity Tests; Mutation; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus aureus; Structure-Activity Relationship; Substrate Specificity | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus.
Topics: Amino Acid Sequence; Bacterial Proteins; Chloramphenicol; Drug Resistance, Multiple, Bacterial; Ethidium; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Onium Compounds; Organophosphorus Compounds; Phylogeny; Sequence Homology, Amino Acid; Sodium Dodecyl Sulfate; Staphylococcus aureus; Trimethoprim; Vancomycin | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
The temperature sensitive mutant 72c. I. Pleiotropic growth behaviour and changed response to some antibiotics and mutations in the transcription or translation apparatus.
Topics: Chloramphenicol; Chromosome Mapping; Chromosomes, Bacterial; Escherichia coli; Fusidic Acid; Genes; Mutation; Phenotype; Protein Biosynthesis; Transcription, Genetic; Trimethoprim | 1978 |
The absorption of antibiotics in adult patients with coeliac disease.
Topics: Adult; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Celiac Disease; Cephalexin; Clindamycin; Erythromycin; Ethics, Medical; Fusidic Acid; Humans; Intestinal Absorption; Lincomycin; Pivampicillin; Rifampin; Sulfamethoxazole; Trimethoprim | 1975 |
In vitro and in vivo activity of coumermycin and other antibacterial agents against methicillin-resistant strains of Staphylococcus aureus.
Topics: Aminocoumarins; Animals; Anti-Bacterial Agents; Coumarins; Drug Combinations; Female; Fusidic Acid; Methicillin; Mice; Microbial Sensitivity Tests; Neutropenia; Penicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1986 |
Antibiotics and human monocyte function. I. Chemotaxis.
Topics: Adult; Anti-Bacterial Agents; Chemotaxis, Leukocyte; Female; Fusidic Acid; Humans; Male; Monocytes; Tetracycline; Trimethoprim | 1987 |
A stable method for calculating oral drug absorption rate constants with two compartment disposition.
Topics: Administration, Oral; Animals; Dogs; Fusidic Acid; Humans; Intestinal Absorption; Kinetics; Mathematics; Pharmaceutical Preparations; Pyridines; Time Factors; Trimethoprim | 1973 |
Serological types of Diplococcus pneumoniae strains isolated in Germany. Comparison with type patterns in other countries.
Topics: Cephaloridine; Chloramphenicol; Drug Combinations; Erythromycin; Fusidic Acid; Germany, West; Humans; Lincomycin; Microbial Sensitivity Tests; Nitrofurans; Novobiocin; Penicillin Resistance; Penicillins; Respiratory Tract Infections; Serotyping; Sputum; Streptococcus pneumoniae; Sulfamethoxazole; Sulfonamides; Tetracycline; Trimethoprim; Vancomycin | 1974 |
[Actual medical importance and antibiotic resistance of staphylococci].
Topics: Ampicillin; Cephaloridine; Chloramphenicol; Erythromycin; Fusidic Acid; Gentamicins; Germany, West; Lincomycin; Novobiocin; Oxacillin; Penicillin G; Penicillin Resistance; Staphylococcus; Streptomycin; Sulfamethoxazole; Tetracycline; Trimethoprim; Vancomycin | 1972 |
Geographical differences in antibiotic sensitivity patterns: comparison of susceptibility of staphylococci in Poland and Germany.
Topics: Cephaloridine; Chloramphenicol; Erythromycin; Framycetin; Fusidic Acid; Geography; Germany, West; Kanamycin; Lincomycin; Nitrofurantoin; Penicillin Resistance; Penicillins; Poland; Rifampin; Species Specificity; Staphylococcus; Streptomycin; Sulfamethoxazole; Tetracycline; Trimethoprim | 1973 |
The genetic basis of antibiotic resistance in S. aureus: the importance of gene transfer in the evolution of this organism in the hospital environment.
Topics: Anti-Bacterial Agents; Cloxacillin; Cross Infection; DNA, Bacterial; Extrachromosomal Inheritance; Fusidic Acid; Genes; Genetic Linkage; Humans; Methicillin; Novobiocin; Penicillin Resistance; Penicillinase; Skin; Staphylococcal Infections; Staphylococcus; Streptomycin; Transduction, Genetic; Transformation, Genetic; Trimethoprim | 1974 |
Metabolism of guanosine tetraphosphate in Escherichia coli.
Topics: Amino Acyl-tRNA Synthetases; Bacterial Proteins; Chloramphenicol; Colicins; Depression, Chemical; Erythromycin; Escherichia coli; Fusidic Acid; Guanine Nucleotides; Hot Temperature; Hydroxylamines; Peptide Chain Initiation, Translational; Puromycin; Rifampin; RNA, Bacterial; Streptomycin; Tetracycline; Trimethoprim; Valine | 1972 |
[Antibiotic resistance of Staphylococcus aureus isolated rom children. Comparative evolution between 1967 and 1972].
Topics: Adolescent; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Fusidic Acid; Gastroenteritis; Gentamicins; Humans; Infant; Otitis; Respiratory Tract Infections; Skin Diseases; Staphylococcal Food Poisoning; Staphylococcal Infections; Sulfamethoxazole; Trimethoprim; Virginiamycin | 1973 |
Anti-gamma haemolysin as a diagnostic test in staphylococcal osteomyelitis.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Chromatography, DEAE-Cellulose; Female; Fusidic Acid; Hemolysin Proteins; Hemolysis; Humans; Immunoglobulin G; Male; Middle Aged; Osteomyelitis; Staphylococcal Infections; Sulfamethoxazole; Trimethoprim | 1973 |
Clinical value of antistaphylococcal drugs.
Topics: Acute Disease; Anti-Infective Agents; Cephalosporins; Chronic Disease; Czechoslovakia; Drug Evaluation; Endocarditis, Bacterial; Erythromycin; Fusidic Acid; Gentamicins; Humans; Lincomycin; Novobiocin; Osteomyelitis; Penicillins; Recurrence; Rifamycins; Staphylococcal Infections; Sulfamethoxazole; Trimethoprim; Vancomycin | 1973 |
Resistance of Staphylococcus aureus to sulphamethoxazole and trimethoprim.
Topics: Anti-Bacterial Agents; Bacitracin; Bacteriophage Typing; Drug Resistance, Microbial; Folic Acid Antagonists; Fusidic Acid; Humans; Lincomycin; Microbial Sensitivity Tests; Neomycin; Oleandomycin; Penicillin Resistance; Pyrimidines; Staphylococcus; Streptomycin; Sulfamethoxazole; Sulfonamides; Tetracycline; Trimethoprim | 1972 |
Rifampicin-containing antibiotic combinations in the treatment of difficult infections.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Drug Therapy, Combination; Erythromycin; Female; Fusidic Acid; Humans; Infant; Legionnaires' Disease; Male; Meningitis; Middle Aged; Osteomyelitis; Rifampin; Sepsis; Skin Diseases, Infectious; Staphylococcal Infections; Tetracycline; Trimethoprim | 1984 |
Synergy of antibiotics against Streptomyces somaliensis isolates in vitro.
Topics: Drug Therapy, Combination; Erythromycin; Fusidic Acid; Microbial Sensitivity Tests; Penicillins; Rifampin; Streptomyces; Sulfamethoxazole; Trimethoprim | 1998 |
Epidemiosurveillance of antimicrobial compound resistance of Staphylococcus intermedium clinical isolates from canine pyodermas.
Topics: Aminoglycosides; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Cephalexin; Chloramphenicol; Dog Diseases; Dogs; Drug Combinations; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Fluoroquinolones; France; Fusidic Acid; Macrolides; Microbial Sensitivity Tests; Oxacillin; Pyoderma; Retrospective Studies; Sentinel Surveillance; Staphylococcal Infections; Staphylococcus; Sulfadiazine; Tetracyclines; Trimethoprim | 1998 |
Variability in SCCmecN1 spreading among injection drug users in Zurich, Switzerland.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Deoxyribonucleases, Type II Site-Specific; DNA Fingerprinting; DNA Transposable Elements; DNA, Bacterial; Fusidic Acid; Humans; Interspersed Repetitive Sequences; Methicillin; Methicillin Resistance; Molecular Epidemiology; Molecular Sequence Data; Penicillin-Binding Proteins; Polymorphism, Restriction Fragment Length; Staphylococcal Infections; Staphylococcus aureus; Substance Abuse, Intravenous; Switzerland; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 2007 |
DNA microarray profiling of a diverse collection of nosocomial methicillin-resistant staphylococcus aureus isolates assigns the majority to the correct sequence type and staphylococcal cassette chromosome mec (SCCmec) type and results in the subsequent id
Topics: Bacterial Proteins; Fusidic Acid; Methicillin-Resistant Staphylococcus aureus; Multilocus Sequence Typing; Oligonucleotide Array Sequence Analysis; Trimethoprim | 2012 |